Review



nonparametric spearman test  (GraphPad Software Inc)


Bioz Verified Symbol GraphPad Software Inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    GraphPad Software Inc nonparametric spearman test
    Nonparametric Spearman Test, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+spearman+correlation/pmc09431663-250-5-11
    Average 90 stars, based on 1 article reviews
    nonparametric spearman test - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    other:

    Article Title: Patient-Specific Nanoparticle Targeting in Human Leukemia Blood
    Article Snippet: The correlation analysis in Figure and Figures S12–S15 was performed using nonparametric Spearman correlation tests in GraphPad Prism 10.2.2.

    Article Title: Porcine respiratory coronavirus as a model for acute respiratory disease: mechanisms of different infection outcomes.
    Article Snippet: To assess correlation between virological/ immune parameters and pathological measures, a nonparametric Spearman correlation coefficient (ρ) was computed for each pair of measures (viral load, antibody response, T-cell responses and pathology) using GraphPad Prism v 10.0.3.

    Article Title: Matching plasma and tissue miRNA expression analysis to detect viable ovarian germ cell tumors.
    Article Snippet: The correlation coefficient (r) between plasma and tumor tissue miRNA level was calculated using non-parametric Spearman correlation in GraphPad Prism and visualized as a scatter plot (S1 Fig).

    Article Title: Identification of phosphatases that dephosphorylate the co-chaperone BAG3
    Article Snippet: Correlation was calculated using the implemented function of nonparametric Spearman correlation in GraphPad Prism.

    Article Title: Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates
    Article Snippet: Correlation coefficients were determined using the Spearman nonparametric correlation (GraphPad Prism, version 8.4.0; GraphPad, Inc., La Jolla, CA, USA).

    Article Title: Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo
    Article Snippet: Correlation analysis in Fig. A to C were performed using nonparametric Spearman correlation tests, also using GraphPad Prism 8.0.

    Comparison:

    Article Title: Characterization of Non-Cholesterol Sterols in Microglia Cell Membranes Using Targeted Mass Spectrometry.
    Article Snippet: Graphs were created with GraphPad Prism (version 9.3.1, GraphPad Software, Inc., San Diego, CA, USA). .. A method comparison was carried out with the nonparametric Spearman correlation (GraphPad Prism), the Passing–Bablok regression and the Bland–Altman plot (MedCalcR 12.3., Ostend, Belgium). ..



    Similar Products

    90
    RStudio nonparametric spearman's test rstudio corr (data)
    Nonparametric Spearman's Test Rstudio Corr (Data), supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+spearman+s+test+rstudio+corr++data+/pmc12146547-81-16-18
    Average 90 stars, based on 1 article reviews
    nonparametric spearman's test rstudio corr (data) - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc two-tailed, nonparametric spearman correlation test
    Two Tailed, Nonparametric Spearman Correlation Test, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+statistics+graphpad+prism/pm40399675-700-15-20
    Average 90 stars, based on 1 article reviews
    two-tailed, nonparametric spearman correlation test - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman correlation tests
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman Correlation Tests, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+spearman+correlation/pmc11633857-104-10-16
    Average 90 stars, based on 1 article reviews
    nonparametric spearman correlation tests - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman's rank correlation tests graphpad prism version 10.0.0
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman's Rank Correlation Tests Graphpad Prism Version 10.0.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+spearman+s+rank+correlation+tests+graphpad+prism+version+10+0+0/pm38603619-92-6-12
    Average 90 stars, based on 1 article reviews
    nonparametric spearman's rank correlation tests graphpad prism version 10.0.0 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric statistical spearman correlation test using graphpad prism® 9.1.2
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Statistical Spearman Correlation Test Using Graphpad Prism® 9.1.2, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+statistical+spearman+correlation+test+using+graphpad+prism++9+1+2/pmc10823629-100-28-30
    Average 90 stars, based on 1 article reviews
    nonparametric statistical spearman correlation test using graphpad prism® 9.1.2 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    SAS institute spearman nonparametric rank correlation test
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Spearman Nonparametric Rank Correlation Test, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+wilcoxon+test/pm36451287-45-31-36
    Average 90 stars, based on 1 article reviews
    spearman nonparametric rank correlation test - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman’s rank correlation test on graphpad prism
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman’s Rank Correlation Test On Graphpad Prism, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+spearman%E2%80%99s+rank+correlation+test+on+graphpad+prism/pm37238718-64-13-13
    Average 90 stars, based on 1 article reviews
    nonparametric spearman’s rank correlation test on graphpad prism - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    GraphPad Software Inc nonparametric spearman test
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman Test, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/nonparametric+spearman+correlation/pmc09431663-250-5-11
    Average 90 stars, based on 1 article reviews
    nonparametric spearman test - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    SYSTAT nonparametric spearman correlation statistic test mystat 12.0
    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the <t>nonparametric</t> Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.
    Nonparametric Spearman Correlation Statistic Test Mystat 12.0, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/nonparametric+spearmans+test/mystat+12/pm35014479-117-9-16
    Average 90 stars, based on 1 article reviews
    nonparametric spearman correlation statistic test mystat 12.0 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the nonparametric Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.

    Journal: Biomaterials Research

    Article Title: Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In Vivo

    doi: 10.34133/bmr.0112

    Figure Lengend Snippet: Repeat injection of Comirnaty marginally induced PEG-specific antibodies. The concentration of anti-PEG antibodies in mouse plasma was assessed on day 28 after each vaccination. (A) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (B) A comparison of the concentrations of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 1 (◯) ( n = 10). (C) A comparison of the concentrations of anti-PEG IgG before vaccination and after 3 doses of Comirnaty in group 2 (△) ( n = 10). (D) A comparison of the concentration of anti-PEG IgM before vaccination and after 3 doses of Comirnaty in group 2 (△) (prevax and 1st dose, n = 10; 2nd dose and 3rd dose, n = 9). (E) Cross-comparison of the fold-change (log 10 ) of anti-PEG IgG and IgM (F) among the 3 cohorts: naïve groups (prevax/3rd dose, n = 10), group 1 (prevax/3rd dose, n = 10), and group 2 (prevax/3rd dose, n = 9). (E and F) Data were derived by the nonparametric Kruskal–Wallis test with Dunn’s multiple comparisons test ( n = 10 in naïve group and group 1; n = 9 in group 2). Prevax, prevaccination; 3rd dose, 3rd dose of Comirnaty vaccination.

    Article Snippet: Correlation analysis in Fig. A to C were performed using nonparametric Spearman correlation tests, also using GraphPad Prism 8.0.

    Techniques: Injection, Concentration Assay, Clinical Proteomics, Comparison, Derivative Assay